Immunology Products & Reviews

Closed, scalable electroporation system for GMP-compliant cell therapy manufacturing.

Accurately quantitate immunosuppressive drug levels in human whole blood samples with MassTrak Immunosuppressant Calibrator, Quality Control, and Internal Standard sets.

Our unique combination of custom antibody development, lateral flow  development and manufacturing services, signal enhancement technology and our mobile diagnostic platform are shaping the future of lateral flow. Our partnership approach allows you to work with one company to reach your assay goals.

BBI Solutions’ Novarum™ technology transforms a smartphone into a mobile diagnostic platform, empowering users to read and share the results of rapid tests at the point of care.  

High sensitivity, specificity, and accuracy

Approved by ANSM in France

Confirm and Differentiate HIV-1 and HIV-2

Fully automated system

in vitro detection of antibodies to HIV-1 and HIV-2

Approved by Health Authorities in many European Countries

Detection of both current and past infection with H. pylori

Accumax LF pipette tips known for Low Force with maximum efficiency are designed to fit Rainin®LTS®style pipette, providing accuracy, precision and ergonomics you have come to expect when using your RAININ®style pipette. It provides a perfect seal between the pipette and tips with minimal effort.

iFuge HCT NXT is a compact hematocrit centrifuge ideal for determining erythrocyte fractions in blood using its 24 place capillary rotor

Target Sufficiency® is the ability of a target system to respond to a therapeutic. It reflects the abundance and forms of the drug target protein, as well as other key system proteins that connect the target to disease phenotypes and enable response. Assessment of the target system requires an analysis platform that can simultaneously capture multiple precise protein measurements.

Monoclonal Anti-Claudin-18.2 Antibody, Mouse IgG1 (3B10) was developed to be exquisitely CLDN18.2 specific, characterized as not cross-reacting with CLDN18.1 and without background staining.

Fungitell® is the first and the only FDA-cleared and CE marked rapid in vitro diagnostic screening test for IFI (including Candida, Aspergillus and Pneumocystis) that detects (1→3)-β-D-Glucan in serum.

Fungitell STAT® is the first and only single sample format FDA-cleared and CE marked rapid in vitro diagnostic screening test for IFI (including Candida, Aspergillus and Pneumocystis) that detects (1→3)-β-D-Glucan in serum.

Beacon Diagnotics® Laboratory is a fully CLIA-certified reference laboratory specializing in (1→3)-β-D- Glucan analysis 

Efficient and intelligent solutions for large immunology labs

The InviRapid ® lateral flow test strips provide a fast and easy detection of diverse allergens within just a few minutes. These assays are suitable for on-site analysis, and do not require any laboratory equipment. They are user-friendly, even for inexperienced personnel, and can be applied in all stages of the food production process - from testing raw materials to finished good samples, and as part of the surface cleaning…

Accumax Low Force Pipettes – the solution to your pipetting woes. Say goodbye to the pain and discomfort of traditional pipettes, and say hello to a new level of ease and precision. With our innovative design, you’ll experience reduced hand strain and fatigue, allowing you to pipette for longer periods without discomfort. Our low force technology ensures smooth and effortless operation, giving you accurate and consistent resu…

Opal 6-Plex Detection Kits - for Whole Slide Imaging (formerly Opal Polaris 7 Color IHC Detection Kits)

Tumors characterized as "hot" exhibit signs of inflammation, high T cell infiltration, and expression of PD-L1. These inflamed tumors typically respond well to checkpoint inhibitor immunotherapy. PhenoCode Signature Immuno-Contexture panel (CD8, CD68, PD-L1, FoxP3, PanCK) enables profiling of the tumor microenvironment for CD8+ T lymphocytes and PD-L1 expression. Map additional phenotypes by adding a 6th marker to the panel fr…

The composition of immune cells within the tumor microenvironment, such as T cells, B cells, and macrophages, varies between tumors and is strongly associated with outcomes to combination therapies. PhenoCode Signature Immune Profile panel enables profiling of the tumor microenvironment using 4 key immune cell markers (CD8, CD68, CD3e, CD20) and a tumor marker (PanCK). Map additional phenotypes by adding a 6th marker to the pa…

The ability to determine whether tumor cells are proliferating and T cells are activated could provide important information about the anti-tumor response and be an indicator of prognosis. PhenoCode Signature Activated TIL Status panel (CD8, CD3e, Ki67, Granzyme B, PanCK) enables determination of Ki67 positivity in addition to profiling of the tumor microenvironment for CD8+ T lymphocytes that are activated. Map additional phe…